Erector Spinae Plane Block for Analgesia During ESWL

NCT07067996 | Recruiting

• 1 other identifier: Soh-Med--25-6-8MS
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

this study aims to compare between efficacy of erector spinae plane block and conventional multimodal analgesia in Extracorporeal shock wave lithotripsy

Conditions

Renal Stone

Outcome Measures

Primary Outcomes (1)

• This study aims to evaluate the efficacy of Erector Spinae Plane Block analgesia for patients undergoing ESWL &compare between it and conventional multimodal Analgesia .

  postoperative pain by visual analog score from 0 to 10 (where 0 indicates no pain and 10 the worst possible pain

  6 hours postopertive

Study Arms (2)

group A : will receive Erector Spinae Plane Block in the prone position after URS.

ACTIVE COMPARATOR

* Patients in the block group (Group A)will receive the ESPB in the prone position after URS. ESPB needle insertion sites will be tolerated to the location of the stone, between T7-T10 vertebra levels. With these adjustments, Following the marking of the thoracic vertebrae levels with a marker pen, * The intervention will be initiated when the transverse processes and costotransverse joints on the relevant level will be distinguished using a high frequency(10-15 MHZ) linear ultrasound probe. The needle will be inserted at a 30° angle to the skin in an in-plane and craniocaudal fashion * Proper placement will be confirmed with ultrasonography and then 20 mL of 0.25% bupivacaine solution\&5 ml lidocaine 1% will be administered through the needle for intraoperative and postoperative anaglesia.

Procedure: erector spinae plane block

group B : will receive nalbuphine

ACTIVE COMPARATOR

•(Group B) patients will receive opioids ,nalbuphine( ,1 )mg/kg over 10 minutes then repeat the dose if needed \&monitoring patients for respiratory depression

Drug: Nalbuphine

Interventions

erector spinae plane block PROCEDURE

erector spinae plane block will be given as intraoperive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

group A : will receive Erector Spinae Plane Block in the prone position after URS.

Nalbuphine DRUG

Nalbuphine will be given as intraopertive analgesia for patients undergoing Extracorporeal shock wave lithotripsy

group B : will receive nalbuphine

Eligibility Criteria

• Age: 21 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Adult Patients undergoing ESWL with 2-3 cm renal stones
• patients between the ages of 21 and 60,
• both sexes,
• BMI ≥18≤30 kg/m²
• Able to give informed consent.
• Patients older than 18 years with American Society of Anesthesiologists Physical Status I or II and

You may not qualify if:

• Coagulopathy or on anticoagulants
• Infection at the ESPB injection site
• BMI ≥30 kg/m²
• Patient refusal.
• patients with advanced respiratory, renal, hepatic, neurological, or psychiatric disease, pregnant or nursing women.
• patients with a history of allergies to any study drugs

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

RECRUITING

Related Publications (3)

• Karaaslan M, Olcucuoglu E, Kurtbeyoglu S, Tonyali S, Yilmaz M, Odabas O. Erector spinae plane block prior to extracorporeal shock wave lithotripsy decreases fluoroscopy time and promise a comfortable procedure for renal stones: A prospective randomized study. Actas Urol Esp (Engl Ed). 2023 Nov;47(9):566-572. doi: 10.1016/j.acuroe.2023.04.001. Epub 2023 Apr 20. English, Spanish.

  PMID: 37084807 RESULT

• Yayik AM, Ahiskalioglu A, Erguney OD, Oral Ahiskalioglu E, Alici H, Demirdogen SO, Adanur S. Analgesic efficacy of ultrasound-guided quadratus lumborum block during extracorporeal shock wave lithotripsy. Agri. 2020 Jan;32(1):44-47. doi: 10.5505/agri.2017.54036.

  PMID: 32030700 RESULT

• Alhashemi JA, Kaki AM. Dexmedetomidine in combination with morphine PCA provides superior analgesia for shockwave lithotripsy. Can J Anaesth. 2004 Apr;51(4):342-7. doi: 10.1007/BF03018237.

  PMID: 15064262 RESULT

MeSH Terms

Conditions

Nephrolithiasis

Interventions

Nalbuphine

Condition Hierarchy (Ancestors)

Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Urolithiasis; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Morphinans; Opiate Alkaloids; Alkaloids; Heterocyclic Compounds; Heterocyclic Compounds, Bridged-Ring; Heterocyclic Compounds, 4 or More Rings; Heterocyclic Compounds, Fused-Ring; Phenanthrenes; Polycyclic Aromatic Hydrocarbons; Polycyclic Compounds

Central Study Contacts

Amr A Abdelaziz, resident

CONTACT

01112942400; amrabdelaziza425@gmail.com

Khaled M Hassan, professor

CONTACT

01144357827

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident, Anesthesia,Sugical Icu,Pain management Faculty of Medicine Sohag Univesity

Study Record Dates

• First Submitted: July 6, 2025
• First Posted: July 16, 2025
• Study Start: June 13, 2025
• Primary Completion: December 15, 2025
• Study Completion: December 15, 2025
• Last Updated: July 16, 2025

Record last verified: 2025-07

Locations

EG (1)